NCT02470832View on ClinicalTrials.gov

A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RG1662 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Healthy Patient Study
Interventions
DRUG

RG1662

DRUG

itraconazole

Trial Locations (1)

LS2 9LH

Leeds

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02470832 - A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RG1662 in Healthy Subjects | Biotech Hunter | Biotech Hunter